SKIP000575 |
SKIP ID |
SKIP000575 |
Organism(En) |
- |
Organism(Ja) |
- |
Cell Type(En) |
- |
Cell Type(Ja) |
- |
Cell Tissue(En) |
unknown |
Cell Tissue(Ja) |
不明 |
Cell Origin |
Normal |
Cell Name 1(En) |
CB |
Cell Name 1(Ja) |
CB |
Cell Name 2(En) |
- |
Cell Name 2(Ja) |
- |
Disease Name 1(Ja) |
- |
ICD Code 1 |
- |
Disease Name 1(En) |
- |
OMIM1 |
- |
Disease Name 2(Ja) |
- |
ICD Code 2 |
- |
Disease Name 2(En) |
- |
OMIM 2 |
- |
Disease Name 3(Ja) |
- |
ICD Code 3 |
- |
Disease Name 3(En) |
- |
OMIM 3 |
- |
Age |
- |
Age Range |
-- |
Sex |
-- |
Race(En) |
- |
Race(Ja) |
- |
Genetic Diagnosis |
-- |
Not Detected |
No |
Description(En) |
Nomal human IPS cell line |
Description(Ja) |
正常iPS細胞株 |
Cell Morphology |
human ES-like |
Grade |
Research Grade |
Vector |
Retrovirus |
Transgene |
pMXs-Oct4, pMXs-Sox2, pMXs-Klf4, and pMXs-c-Myc |
Adhesiveness |
Yes |
Feeder |
Yes |
Feeder Cell |
MEFs |
Medium |
DMEM/F12, 20% KSR, MEM NEAA, 0.1mM 2-Mercaptoethanol, 5ng/ml human bFGF, penicillin-streptomycin-glutamine |
Genome Editing |
- |
CO2 |
0 |
Mycoplasma |
- |
Detection of Contaminants Mycoplasma |
- |
Pluripotent Markers |
Yes |
Pluripotent Markers Assay |
Fluorescence immunostaining |
in vitro Differentiation |
- |
in vitro Differentiation Assay |
- |
in vivo Differentiation |
- |
in vivo Differentiation Assay |
- |
Other 1 Assay |
- |
Other 1 Assay Method |
- |
Other 2 Assay |
- |
Other 2 Assay Method |
- |
Other 3 Assay |
- |
Other 3 Assay Method |
- |
Karyotype |
- |
Karyotype Assay |
- |
Remaining Vector Detection |
- |
Remaining Vector Detection Assay |
- |
STR |
- |
HLA |
- |
Stem Cell Transcriptome analysis |
- |
Stem Cell Transcriptome analysis Assay |
- |
Author Name(En) |
Masataka Hosoi |
Author Name(Ja) |
Masataka Hosoi |
Author Organization(En) |
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo |
Author Organization(Ja) |
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo |
Author Contact Email |
- |
PI Organization(En) |
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo |
PI Organization(Ja) |
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo |
PI Name(En) |
Mineo Kurowaka |
PI Name(Ja) |
Mineo Kurowaka |
PI Contact Email |
- |
Availability |
Information Only |
Provider Organization(En) |
- |
Provider Organization(Ja) |
- |
Provider Email |
- |
Provider URL |
- |
Ethical Statement(En) |
- |
Ethical Statement(Ja) |
- |
Terms of Use(En) |
- |
Terms of Use(Ja) |
- |
PubMed ID |
24859480 |
DOI |
10.1016/j.exphem.2014.03.010 |
Title |
Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples. |
Authors |
Hosoi M, Kumano K, Taoka K, Arai S, Kataoka K, Ueda K, Kamikubo Y, Takayama N, Otsu M, Eto K, Nakauchi H, Kurokawa M |
Journal |
Exp Hematol |
Year |
2014 |
Volume |
42 |
Issue |
9 |
Pages |
816-25 |
URL |
http://www.ncbi.nlm.nih.gov/pubmed/24859480 |
Free input |
- |
Note |
- |